Automated and high-throughput systems accelerate time to final drug product
Our deep understanding of the nature of large molecules derived from our drug substance development activities serves as the basis to efficiently develop a formulation. This synergistic approach enables us to provide targeted and rapid drug product development.
Whilst applying a broad array of high-throughput technologies, we provide rapid formulation development accompanied by simultaneous real-time and accelerated stability testing according to ICH standards.
We use a semiautomatic filling machine to determine critical process parameters and to produce aseptic drug product for preclinical studies.
Automated and high-throughput formulation development:
We provide rapid and highly automated formulation development to our partners, utilizing:
UNit 445 for rapid excipient screening
Freeslate Protegé 300 for automated visible particles, colour and turbidity measurements
Semi-automated filling and crimping station
DSC for melting temperatures determination
Working with our Drug Product Team
“We are committed to positive outcomes and delivering projects on time to specification”
We can support any projects formulation development and utlize our know-how, state-of-the-art equipment and technologies to deliver a formulation optimized for your therapeutic.
Warning against fraudulent internet recruitment activities:
Our attention has been drawn to the fraudulent activities of persons posing as recruitment agencies or Polpharma Biologics employees. The fraud involves sending people a request for personal information, making job offers and/or extorting fees for recruitment-related accommodation or preparation sessions ahead of an interview or assessment centre. We would like to make it clear that Polpharma Biologics never requires candidates to make payment during a recruitment process.
Read more here.
PL
EN
